Overview
Human Gene Therapy and HGT Methods: 18 Issues
Print ISSN: 1043-0342 Online ISSN: 1557-7422
Human Gene Therapy is the premier, multidisciplinary journal covering all aspects of gene therapy. The Journal publishes in-depth coverage of DNA, RNA, and cell therapies by delivering the latest breakthroughs in research and technologies. Human Gene Therapy provides a central forum for scientific and clinical information, including ethical, legal, regulatory, social, and commercial issues, which enables the advancement and progress of therapeutic procedures leading to improved patient outcomes, and ultimately, to curing diseases.
The Journal has expanded into two parts. Part A (Human Gene Therapy, the flagship) is published 12 times per year. Part B, HGT Methods, a bimonthly journal, focuses on the applications of gene therapy to product testing and developments. Subscribers have the option of subscribing to both Human Gene Therapy and HGT Methods, or HGT Methods can be ordered separately for those interested exclusively in methods technologies.
Human Gene Therapy and HGT Methods coverage includes:
- Improvements in vector developments
- Delivery systems
- Cell therapy
- Small nucleic acid therapeutics, including RNAi
- Clinical trials and animal models
Human Gene Therapy was voted one of the most influential journals in Biology and Medicine over the last 100 years by the Biomedical & Life Sciences Division of the Special Libraries Association.
Human Gene Therapy and part B, HGT Methods, are under the editorial leadership of Editor-in-Chief James M. Wilson, MD, PhD, University of Pennsylvania School of Medicine, Gene Therapy Program, Department of Pathology and Laboratory Medicine; Deputy Editor George Dickson, Institute of Biomedical & Life Sciences, School of Biological Sciences, University of London; Methods Editor Thierry VandenDriessche, PhD, Free University of Brussels (VUB); and other leading investigators. View the entire editorial board.
Audience: Geneticists, medical geneticists, biological scientists, microbiologists, molecular biologists, virologists, experimental researchers, and experimental medicine specialists, among others.
Human Gene Therapy and HGT Methods provide “Instant Online” publication 72 hours after acceptance
The Official Journal of nine international societies:
Subscribe to HGT Methods today
Click Human Gene Therapy and HGT Methods for the complete package information and to subscribe.
[ Back to Top ]
 |
| Dr. James Wilson |
 PODCAST SERIES: Dr. James Wilson, Editor of Human Gene Therapy interviews leading members in the field of gene therapy including Andrew Baker & Lynda Coughlan from the University of Glasgow, Luigi Naldini from the San Raffaele Telethon Institute for Gene Therapy, Thierry VandenDriessche from the Free University of Brussels & the University of Leuven in Belgium, and Seppo Yla-Herttuala of ESGCT.
|
|
*Audio plays in a popup window. Please make sure your popup blocker is off.
|
|
 Dr. Terence R. Flotte Dean of University of Massachusetts Medical School, discusses the role of gene and cell therapy in the era of health care reform. Featured commentary from Dr. Flotte, and co-author Walter H. Ettinger, on the topic is available here. LISTEN NOW!*
|
|
 Thierry VandenDriessche, Professor in Medicine for the Free University of Brussels and the University of Leuven in Belgium, discusses the use of vector AAV to treat patients with hemophilia B. LISTEN NOW!*
|
|
 Andrew Baker discusses his approach of targeting vectors to endothelial cells of vascular grafts, among other newsworthy topics. LISTEN NOW!*
|
|
 Lynda Coughlan, Research Associate at the University of Glasgow and an advocate for early-career researchers to the British Society for Gene Therapy, has organized a workshop to be held at the ESGCT conference on "Careers in Science." She describes what the session will hold. LISTEN NOW!*
|
|
 Luigi Naldini, the Scientific Director for the San Raffaele Telethon Institute for Gene Therapy in Milano, Italy, discusses the progress, benefits, and possible challenges of ex vivo lentiviral gene transfer techniques. LISTEN NOW!*
|
|
Thierry VandenDriessche, Professor in Medicine for the Free University of Brussels and the University of Leuven in Belgium, discusses the great advancements made in the clinical development of gene therapy in European countries. LISTEN NOW!*
|
|
 Seppo Yla-Herttuala, President of the ESGCT, discusses the expanding field of cell and gene therapy—from important advances to upcoming challenges—as well as updates from his own current research. LISTEN NOW!*
|